SYNERGY-OUTCOMES Study Examines Retatrutide for Liver Disease Prevention | Retatrutide News

The SYNERGY-OUTCOMES study is investigating retatrutide and tirzepatide for preventing liver issues in MASLD. The trial will enroll about 4,500 adults o...
Clinical Trials · October 16, 2026